Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salvatore Cuzzocrea

Showing results (1-10 of 834) with videos related to

Pageof 84
Sort By:
Current Pharmaceutical Design|October 5, 2006
Role of nitric oxide and reactive oxygen species in arthritisSalvatore Cuzzocrea
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging biotherapies for inflammatory bowel diseaseSalvatore Cuzzocrea
Arthritis Research & Therapy|September 23, 2011
Characterization of a novel and spontaneous mouse model of inflammatory arthritisSalvatore Cuzzocrea
Pharmacological Research|May 25, 2005
Shock, inflammation and PARPSalvatore Cuzzocrea
Current Opinion in Pharmacology|April 4, 2006
Peroxisome proliferator-activated receptors and acute lung injurySalvatore Cuzzocrea
Pharmacological Research|May 24, 2014
Reply to Letter to Editor: "Kriek R., Marketing messages in pharmacological papers and scientific chapters: The case of palmitoylethanolamide and its formulations" [Pharmacol Res (2014) 10.1016/j.phrs.2014.04.007]Salvatore Cuzzocrea
Vascular Pharmacology|January 18, 2005
Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injurySalvatore Cuzzocrea
Shock (Augusta, Ga.)|March 29, 2024
RE: GITR GENE DELETION AND GITR-FC SOLUBLE PROTEIN ADMINISTRATION INHIBIT MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN. DOI: 10.1097/SHK.0B013E3182262C48Salvatore Cuzzocrea
Expert Opinion on Therapeutic Targets|July 12, 2011
Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injuryEmanuela Esposito, Salvatore Cuzzocrea
CNS & Neurological Disorders Drug Targets|March 22, 2016
Neuroinflammation and Immunity: A New Pharmacological Target in DepressionRosalia Crupi, Salvatore Cuzzocrea
Pageof 84

Showing results (1-10 of 834) with videos related to

Sort By:
Pageof 84
Current Pharmaceutical Design|October 5, 2006
Role of nitric oxide and reactive oxygen species in arthritisSalvatore Cuzzocrea
Expert Opinion on Emerging Drugs|December 10, 2003
Emerging biotherapies for inflammatory bowel diseaseSalvatore Cuzzocrea
Arthritis Research & Therapy|September 23, 2011
Characterization of a novel and spontaneous mouse model of inflammatory arthritisSalvatore Cuzzocrea
Pharmacological Research|May 25, 2005
Shock, inflammation and PARPSalvatore Cuzzocrea
Current Opinion in Pharmacology|April 4, 2006
Peroxisome proliferator-activated receptors and acute lung injurySalvatore Cuzzocrea
Pharmacological Research|May 24, 2014
Reply to Letter to Editor: "Kriek R., Marketing messages in pharmacological papers and scientific chapters: The case of palmitoylethanolamide and its formulations" [Pharmacol Res (2014) 10.1016/j.phrs.2014.04.007]Salvatore Cuzzocrea
Vascular Pharmacology|January 18, 2005
Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injurySalvatore Cuzzocrea
Shock (Augusta, Ga.)|March 29, 2024
RE: GITR GENE DELETION AND GITR-FC SOLUBLE PROTEIN ADMINISTRATION INHIBIT MULTIPLE ORGAN FAILURE INDUCED BY ZYMOSAN. DOI: 10.1097/SHK.0B013E3182262C48Salvatore Cuzzocrea
Expert Opinion on Therapeutic Targets|July 12, 2011
Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injuryEmanuela Esposito, Salvatore Cuzzocrea
CNS & Neurological Disorders Drug Targets|March 22, 2016
Neuroinflammation and Immunity: A New Pharmacological Target in DepressionRosalia Crupi, Salvatore Cuzzocrea
Pageof 84